SCHEMBL17211830

SCHEMBL17211830

CCOC(=O)C(C)(C)C1CCc2cc(C)ccc2C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 1/20 0.39
▸ PARP11 Q9NR21 1/20 0.39
▸ METAP1 P53582 1/20 0.37
▸ CYP24A1 Q07973 3/20 0.37
▸ CYP27A1 Q02318 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ CYP26A1 O43174 3/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14137074 0.89 CYP26A1 (0.46) CYP24A1ALDH1A1KDM4EMEN1MAPT
SCHEMBL14062029 0.87 CYP24A1 (0.49) METAP1CYP24A1CYP27A1CYP26A1SMN1; SMN2
SCHEMBL14062034 0.84 CYP26A1 (0.39) CYP24A1ALDH1A1KDM4EMEN1MAPT
SCHEMBL14137073 0.83 DRD2 (0.44) CYP24A1CYP27A1CYP26A1ACHE
SCHEMBL13954369 0.83 ALDH1A1 (0.36) PARP10PARP11METAP1CYP24A1CYP27A1
SCHEMBL14062072 0.81 ALDH1A1 (0.39) ALDH1A1MAPTKMT2AGAARAB9A
SCHEMBL2472482 0.79 CYP24A1 (0.50) METAP1CYP24A1CYP27A1CYP26A1ACHE
SCHEMBL17195438 0.75 CYP24A1 (0.46) METAP1CYP24A1CYP27A1CYP26A1ACHE
SCHEMBL14137075 0.73 DGAT1 (0.57) MEN1MAPTKMT2ARAB9ALMNA
SCHEMBL17211829 0.73 CYP24A1 (0.44) METAP1CYP24A1CYP27A1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242929-B2 Compounds as diacylglycerol acyltransferase inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-01-26 — — US disclosed
US-20150307445-A1 Novel Compounds as Diacylglycerol Acyltransferase Inhibitors GlaxoSmith Kline Intellectual Property (No.2) Limited (GB) 2015-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307445-A1 Novel Compounds as Diacylglycerol Acyltransferase Inhibitors DGAT1, DGAT2, LCAT PARP10 1366/4885PARP11 1513/4885METAP1 1077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback